Navigation path

Additional tools

  • Print version
  • Decrease text
  • Increase text
  • Choose high contrast version
  • Choose standard colour version

Profile of registrant

H. Lundbeck A/S

Identification number in the register: 17547932636-11
Registration date: 18/11/09 13:37:16

The information on this organisation was last modified on 06/11/13 13:49:11
The date of the last annual update was 06/11/13 13:30:37

Registrant : Organisation or self-employed individual

Name/company name: H. Lundbeck A/S
Acronym: Hlu
Legal status: •internt ansatte repræsentanter og brancheforeninger, der er aktive inden for lobbyvirksomhed
Website address:


Section: II - In-house lobbyists and trade/professional associations
and more precisely: Companies & groups

Person with legal responsibility

Surname, Name: Ulf Wiinberg
Position: CEO

Permanent person in charge of EU relations

Surname, Name: Neil Mulcock
Position: Global Public Affairs Director

Contact details:

Contact details of organisation's head office: 9 Ottiliavej 
Valby 2500
Telephone number: (+45) 36301311
Fax number: (+) 
Other contact information:

Goals / remit

Goals / remit of the organisation: H. Lundbeck A/S (LUN.CO, LUN DC, HLUKY) is an international pharmaceutical company highly committed to improve the quality of life for people suffering from disorders in the central nervous system (CNS). For this purpose Lundbeck is engaged in the research and development, production, marketing and sale of pharmaceuticals across the world, targeted at disorders like depression and anxiety, alcohol dependence, schizophrenia, insomnia, Huntington's, Alzheimer's and Parkinson's diseases.

Lundbeck was founded by Hans Lundbeck in 1915 in Copenhagen, Denmark, and today employs 5,900 people worldwide. Lundbeck is one of the world's leading pharmaceutical companies working with CNS disorders. In 2012, the company's revenue was DKK 14.8 billion. For more information, please visit
The organisation's fields of interests are:
  • global

Number of persons engaged in activities falling under the scope of the Transparency Register

Number of persons: 10
Complementary information:

Persons accredited for access to European Parliament premises

No accredited persons


Main EU initiatives covered the year before by activities falling under the scope of the Transparency Register:

Legislation and public policy areas relevant for the pharmaceutical industry and Lundbeck's focus within central nervous system disorders, eg. mental health

Fields of interest for e-mail alerts on consultations and roadmaps;

Fields declared by the organisation:
  • Employment and Social Affairs
  • Enterprise
  • Justice and Fundamental Rights
  • Public Health
  • Research and Technology


Information on (i) organisation's membership of any associations/federations/confederations or (ii) relationships to other bodies in formal or informal networks.

Efpia - European Federation of Pharmaceutical Industries and Associations

DI - Confederation of Danish Industry

Lif - The Danish Association of the pharmaceutical industry

Ifpma - International Federation of Pharmaceutical Manufacturers & Associations

Financial data

Financial year: 01/2012 - 12/2012
Estimated costs to the organisation directly related to representing interests to EU institutions in that year: 400000  € - 450000  €
Amount and source of funding received from the EU institutions in financial year n-1 of registration
Procurement: 0 €
Grants: 0 €
Other (financial) information provided by the organisation:

Code of conduct

By its registration the organisation has signed the Transparency Register Code of Conduct.